This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
When Should I Change My Budget During The Month provides practical timing advice to adjust your plan responsibly as circumstances evolve.
26,475 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
A new, Lubin-backed nonprofit launches to accelerate institutional adoption of Ethereum and its Layer 2 ecosystem. Th...
SpaceX blends rockets, satellites, and AI dreams. This piece examines whether could spacex eventually become the top ...
The BEA final read confirms economy grew 2.1% first quarter, signaling momentum. Here’s what drove growth and what ho...
As AI infrastructure spending persists into July, Teradyne, Ouster, and Vishay Precision Group lead a rally in infras...
A CEO sold 30,000 shares and sparked questions about beta's future. This guide breaks down what insider sales really ...
Bitcoin sits in a bitcoin deep value zone as on-chain signals show ongoing selling pressure from long-term holders. T...
Tesla could redefine AI profitability by owning the stack from hardware to the finished product. A new investment the...
A July 12 KBW report argues artificial intelligence will fortify the industry’s largest lenders rather than upend the...
As the 2026 COLA rises to 2.8%, investors turn to steady income stocks that more than cover the gap. A trio of picks ...
Oracle’s stock has fallen from its AI-redemption peak as management bets heavily on data-center compute. Analysts are...
The United States is imposing 25% tariffs on imports from Brazil, with exemptions for key items like coffee and beef....